• Strive Health

  Participated · Series C · May 2023

  Strive Health is a Denver, CO-based company specializing in value-based kidney care and a partner of choice for innovative healthcare payors and providers. The company combines AI technology, care interventions and integration with local providers to form an integrated care delivery system that supports the patient journey from chronic kidney disease (CKD) to end-stage kidney disease (ESKD). It partners with commercial and Medicare Advantage payors, Medicare, health systems and physicians through flexible value-based payment arrangements, including risk-based programs. Strive serves over 145,000 people with CKD and ESKD across 50 states and partners with more than 6,500 providers; its case management and population health programs are NCQA-accredited and its CareMultiplier platform is HITRUST-certified. The company is led by CEO Chris Riopelle. It intends to use the new capital to enhance end-to-end strategic partnerships, grow multi-specialty services and enhance its value-based care model through advanced technology, including AI-driven tools and analytics. Strive completed a $300M Series D equity round and secured $250M in debt financing for a combined $550M capital raise. Strive Health delivers value-based, technology-enabled kidney care by ingesting patient data and applying machine learning to stage disease and predict progression, enabling targeted interventions. The company launched in April 2020 with 700 patients in St. Louis and has expanded significantly since. Today it serves 80,000 patients across 30 states, partners with over 600 nephrology providers in 10 states, and employs 550 people. Strive manages over $2.5 billion of annual medical spending and reports its care model has produced over a 20% reduction in total kidney care costs and a 42% reduction in hospitalizations. Leadership declined to disclose specific revenue figures but said the company has been growing rapidly. The company plans to invest the new capital in technology development, expand payor, health system, nephrologist and medical group partnerships, enter new markets, and scale further in the 30 states where it already operates. Strive Health delivers a whole-patient, value-based kidney care model that pairs AI-powered predictive analytics with specially trained clinicians (“Kidney Heroes”) to slow chronic kidney disease progression, prevent hospitalizations, and increase access to home dialysis and transplants. Its data science models reportedly predict disease progression with greater than 95% accuracy, and its programs have shown up to a 29% reduction in total healthcare spend. The company has contracts with payors and providers including Humana, Blue Cross and Blue Shield of North Carolina, SSM Health and Conviva Care Centers, and partnerships with hundreds of nephrology providers through Medicare payment models. Strive says it has more than doubled its presence in regional markets and grown its employee base by over 600% in the last year. The company plans continued expansion and product/go-to-market innovation supported by strategic partners. Strive Health provides an integrated kidney care service powered by specialized technology and nephrology caregivers. The service covers the entire chronic kidney disease journey, from primary care–level prevention through end-stage renal replacement therapy. The company works with innovative payers and providers to deliver its care model. Strive was founded in 2018, is led by CEO Chris Riopelle, and was launched out of Oxeon’s Venture Studio. Recently the company received an investment from Ascension Ventures; the amount was not disclosed.

• Quartet Health

  Led · Series D · Dec 2019

  Quartet Health is an independent technology and services company that uses SmartMatch capabilities enabled by sophisticated data and analytics to connect patients to mental health solutions that fit their preferences, clinical needs, and insurance while linking care to the broader healthcare experience. The company works with health plans, systems, and provider groups to deliver speed to quality behavioral health care, defining quality by speed to care, seamless patient experience, improved outcomes, and affordability. To date nearly 300,000 patients have been referred to Quartet, roughly 80% from primary care; in the first eight months of its work with Independence more than 1,100 clinicians in Southeastern Pennsylvania signed up and over 2,500 members were connected to the platform. Quartet plans to continue enhancing its data and analytics to proactively identify and triage patients, expand an outcomes-driven provider network, and build actionable insights to measure and reward quality through value-based payment models. The company also intends to expand capabilities to support additional conditions such as substance use disorders and serious mental illnesses and to serve additional populations including pediatrics and transitional-age youth. Quartet is backed by venture investors including Oak HC/FT, GV, F-Prime Capital, Polaris Partners, Deerfield Management, Echo Health Ventures, Centene Corporation, and Independence Health Group. Quartet operates an integrated platform that links providers, payers and services to more effectively deliver mental and primary care. The platform supplies physicians with data to identify undetected mental health conditions, enables quick referrals to specialists, and allows providers to share treatment plans; patients receive personalized support from Quartet’s customer service team. Quartet announced a partnership with Cambia Health Solutions to connect mental health patients in the U.S. northwest to appropriate care, initially targeting Washington with plans to expand into Oregon, Idaho and Utah. The company said its Series D will fund expansion efforts and aims to reach Medicaid beneficiaries in need of behavioral health services. Quartet has raised roughly $161 million to date, following prior rounds led by GV (2016), F-Prime Capital Partners and Polaris (2018), and a June contribution from Centene Corporation. The company also experienced executive departures and negative Glassdoor reviews in late 2018. Quartet builds a HIPAA-compliant technology platform and services to integrate mental health into primary care and support collaborative care teams. Its Care Team product enables clinicians, clinically-adjacent providers, and community-based professionals such as case managers to coordinate care, share treatment plans, notes, and clinical assessment updates. Quartet provides physicians with data and resources to better identify patients with underlying mental health conditions and connect them to a trusted network of mental health providers. The company is expanding the Care Team product to support a broader set of members across the full patient journey, a change the company says is especially relevant for Medicaid beneficiaries served by FQHCs and community resources. Quartet announced a strategic partnership with Centene to improve access to mental health care for vulnerable populations. Financially, Quartet completed a $60M Series D round, bringing total funding raised to $153M. Quartet is headquartered in New York City and operates in multiple U.S. markets including Pennsylvania, Washington, Northern California, New Jersey, North Carolina, Louisiana, and Illinois. Quartet Health operates a platform that connects primary care doctors and mental health professionals to coordinate treatment plans and facilitate referrals. The company uses machine learning to help providers identify potential health issues and improve care coordination. Quartet currently operates in six U.S. markets: California, Louisiana, Massachusetts, New Jersey, Pennsylvania and Washington. It was founded in 2014 by CEO Arun Gupta. Quartet plans to use new capital to expand geographically, invest in its technology platform, hire for its machine learning team, and grow its provider network. The company recently added three new directors to its board as it scales. Quartet Health builds a platform that helps primary care doctors and mental-health professionals work together by using data and algorithms to identify patients at risk for comorbid conditions. When risk is detected, the platform refers patients to providers in Quartet’s network or to its online cognitive behavioral therapy and consultation tools. If a patient receives a new diagnosis, Quartet’s system enables coordination of tests, consultations, and prescriptions across providers. The company says it has traction from creating a comprehensive, point-of-care solution that leverages multiple care modalities. Quartet plans to use new capital to enter six new U.S. markets over the next year, including Massachusetts, the Midwest, and the West Coast. Founded in 2014 and based in New York, the company is led by CEO Arun Gupta.

• Dekko

  Participated · Equity · May 2013

  Dekko develops technology that maps the real world using a phone or tablet camera, building digital 3-D grids that allow games and other applications to be layered on top. The company has shifted from primarily offering a developer platform to building its own consumer applications to attract users and demonstrate the platform's capabilities. Its first game is reported to be about 90% complete and is intended to showcase how developers can use the real-world OS. Dekko’s current app focuses on creating grids of small, independent spaces, with potential to map larger, full-scale environments. The company is based in San Francisco and has a team of 10 employees with expertise in augmented reality, optical tracking, 3-D reconstruction and user experience design. Financially, Dekko closed a $3.2M funding round (including an additional $1.3M to close out the round) from a mix of venture firms and angel investors. Dekko provides a context-aware AR platform that accounts for user location, surroundings, and device spatial movement to create more realistic augmented-reality experiences. Its technology works with Unity 3-D and enables developers — including those without prior AR expertise — to build apps that place characters and objects believably in users' environments. The platform can create digital copies of real-world objects and supports interactive experiences; Dekko also has three patents pending. The company has partnered with 40+ content partners across gaming, toys, entertainment IP and special effects, and is working with distribution partners including smartphone manufacturers, carriers, chipset makers, and social/gaming companies. Another 50 developers are signed up to test the platform pre-launch, and Dekko expects commercial apps built on the platform by the end of the year. The company was founded by Matt and Silka Miesnieks and currently has eight employees; it has raised $1.9 million in funding.

No current team members are available.